Datos ng Sahod para sa H1B

Home › Mga Employer › Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc.: Mga sahod ng H-1B at sponsorship

Isinampa ng Kymera Therapeutics, Inc. ang 15 labor condition applications para sa H-1B at kaugnay na visa sa mga fiscal year na 2023–2026; sertipikado: 15. Median offered salary: $135,000.

Mga Aplikasyon (LCAs)15
Sertipikado15
Address ng employerWatertown, MA
Employer na nakadepende sa H-1BHindi
Median na sahod na iminungkahi$135,000
Gitnang bahagi ng mga sahod$116,500–$177,500
Ika-10 hanggang ika-90 percentil$98,000–$214,000

Nag-sponsor ba ang Kymera Therapeutics, Inc. ng mga visa na H-1B?

Isinampa ng Kymera Therapeutics, Inc. ang 15 labor condition applications sa mga fiscal year na 2023–2026, ang pinakabago ay isinampa noong Hun 22, 2026. Ang LCA ay ang unang hakbang ng isang petisyong H-1B, kaya ang employer ay nag-sponsor o naghanda na mag-sponsor ng mga manggagawang H-1B; hindi nito ginagarantiyahan ang sponsorship para sa anumang partikular na trabaho. Tingnan ang sariling listahan ng trabaho ng employer.

Mga sahod ayon sa titulo ng trabaho

Titulo ng TrabahoLCAsMedian na sahod
Associate Director, Translational Medicine2$180,000
Senior Research Associate, Platform Biology1$90,000
Research Associate II, Cellular Assays1$75,000
Senior Scientist, In Vitro Pharmacology1$135,000
Associate Scientist, Platform Biology1$110,000
Senior Scientist, Proteomics1$140,000
Scientist (Discovery Biology)1$120,000
Associate Director, Bioanalytical1$185,000
Principal Scientist, Biological Sciences1$160,000
Scientist, Computational Biology1$130,000
Senior Director, Pharmacovigilance Operations1$280,000
Associate Scientist, Discovery Biology1$125,715
Associate Scientist, Cellular Pharmacology1$113,000
Director, Late Stage Formulations Development1$230,000

Mga aplikasyon ayon sa fiscal year

Piskal na taonLCAsMedian na sahod
FY20234$112,500
FY20242$125,000
FY20255$160,000
FY20264$177,858

Antas ng prevailing wage

Itinakda ng Department of Labor ang apat na antas ng prevailing wage para sa bawat okupasyon at lugar, mula Level I (entry) hanggang Level IV (fully competent). Pinipili ng employer ang antas na tumutugma sa mga kinakailangan ng trabaho.

Kung saan naroroon ang mga trabaho

Mga Okupasyon

Pinakabagong aplikasyon

Titulo ng TrabahoBatayang sahodLokasyonIsumitePetsa ng SimulaStatus
Director, Late Stage Formulations Development$230,000
Antas II
Watertown, MAHun 22, 2026Hul 6, 2026Sertipikado
Associate Scientist, Cellular Pharmacology$113,000
Antas I
Watertown, MAHun 8, 2026Okt 1, 2026Sertipikado
Associate Scientist, Discovery Biology$125,715
Antas II
Watertown, MAMay 1, 2026Okt 1, 2026Sertipikado
Senior Director, Pharmacovigilance Operations$280,000
Antas IV
Watertown, MAMar 10, 2026Mar 12, 2026Sertipikado
Principal Scientist, Biological Sciences$160,000–$180,000
Antas II
Watertown, MAAgo 20, 2025Okt 1, 2025Sertipikado
Scientist, Computational Biology$130,000–$150,000
Antas II
Watertown, MAAgo 18, 2025Okt 1, 2025Sertipikado
Associate Director, Translational Medicine$190,000–$215,000
Antas II
Watertown, MAAgo 1, 2025Okt 1, 2025Sertipikado
Associate Director, Bioanalytical$185,000–$210,000
Antas III
Watertown, MAHun 18, 2025Hul 21, 2025Sertipikado
Scientist (Discovery Biology)$120,000–$140,000
Antas II
Watertown, MAMar 12, 2025May 9, 2025Sertipikado
Senior Scientist, Proteomics$140,000–$160,000
Antas III
Watertown, MAAbr 8, 2024Okt 1, 2024Sertipikado
Associate Scientist, Platform Biology$110,000–$130,000
Antas II
Watertown, MADis 12, 2023Abr 30, 2024Sertipikado
Senior Scientist, In Vitro Pharmacology$135,000–$155,000
Antas III
Watertown, MAAgo 7, 2023Ago 28, 2023Sertipikado
Research Associate II, Cellular Assays$75,000–$90,000
Antas I
Watertown, MAMay 8, 2023Okt 1, 2023Sertipikado
Senior Research Associate, Platform Biology$90,000–$110,000
Antas I
Watertown, MAMay 8, 2023Okt 1, 2023Sertipikado
Associate Director, Translational Medicine$170,000–$190,000
Antas II
Watertown, MAOkt 3, 2022Okt 24, 2022Sertipikado

Ang mga sahod ay ang mababang dulo ng alok na sweldo sa bawat aplikasyon, na isinalin sa taunang halaga; ginagamit lamang ng istatistika ang mga sertipikadong full-time na aplikasyon. Ang LCA ay hindi pag-apruba ng visa at maaaring saklawin ng isang LCA ang ilang posisyon. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (pinakabagong desisyon: Hun 30, 2026).